[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-instituto-de-salud-carlos-iii-isciii-incorporaci-n-de-nuevos-grupos-al-consorcio-centro-2026":3,"similar-instituto-de-salud-carlos-iii-isciii-incorporaci-n-de-nuevos-grupos-al-consorcio-centro-2026":25},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":8,"budget_max_eur":8,"deadline":8,"deadline_note":9,"duration":8,"trl":8,"relevance":8,"why_relevant":8,"early_career":10,"consortium":11,"first_seen":12,"last_updated":8,"update_note":8,"status":13,"stages":8,"call_frequency":14,"next_call_expected":8,"source_url":7,"created_at":15,"updated_at":16,"eligible_countries":17,"description":19,"seo_summary":20,"canonical_id":4,"links":21},"instituto-de-salud-carlos-iii-isciii-incorporaci-n-de-nuevos-grupos-al-consorcio-centro-2026","Incorporación de nuevos grupos al Consorcio Centro de Investigación Biomédica en Red M.P. (CIBER)","Instituto de Salud Carlos III (ISCIII)","https:\u002F\u002Fwww.isciii.es\u002Fen\u002Ffinanciacion\u002Faes\u002Factuaciones-documentacion",null,"Annual competitive call (AES-LEIS); specific deadline not stated on this page",false,"Required — applicant group must join the CIBER network consortium","2026-08-02T00:00:00.000Z","open","Annual","2026-08-02T06:12:03.681Z","2026-08-02T07:07:48.349Z",[18],"ES","Supports incorporation of new research groups into the CIBER (Biomedical Research Networking Centre) consortium. Applicants must be Spanish health research groups seeking institutional strengthening through CIBER membership. Part of AES-LEIS 2024-2027.","{\"summary\":\"This annual ISCIII call supports the incorporation of new Spanish health research groups into the CIBER (Biomedical Research Networking Centre) consortium. CIBER membership provides institutional strengthening and integration into an established national biomedical research network. Eligible applicants are Spanish research groups seeking to formalize their participation in one of CIBER's thematic research areas.\",\"meta_description\":\"ISCIII CIBER incorporation call funds Spanish health research groups joining the CIBER consortium for institutional strengthening, from ISCIII.\",\"who_should_apply\":[\"Spanish health research groups with an established track record\",\"Teams seeking formal membership and institutional integration within CIBER\",\"Groups aligned with one of CIBER's thematic research areas (e.g. cancer, cardiovascular, neurodegenerative, rare diseases, infectious disease, respiratory)\",\"Research teams based at eligible Spanish institutions (universities, hospitals, research centres)\"],\"key_dates\":[\"Annual deadline (verify exact date on ISCIII website for the current AES-LEIS cycle)\",\"Consortium membership begins following approval and formal incorporation\",\"Part of the AES-LEIS 2024-2027 strategic research plan\"],\"tips\":[\"Align your research group's profile explicitly with CIBER's thematic structure; cross-disciplinary fit strengthens incorporation bids.\",\"Demonstrate institutional support and commitment from your host institution, CIBER requires signatories at the governing level.\",\"Letter of intent should clarify the value of CIBER membership to your group's research strategy and positioning within Spanish health research.\"],\"faq\":[{\"q\":\"What is CIBER and why should I apply for incorporation?\",\"a\":\"CIBER is Spain's national Biomedical Research Networking Centre, coordinating research groups across thematic areas to strengthen health research capacity. Membership provides institutional visibility, access to funding streams, and collaborative networks.\"},{\"q\":\"Are non-Spanish research groups eligible for CIBER incorporation?\",\"a\":\"No, this call is restricted to Spanish health research groups based in eligible Spanish institutions.\"},{\"q\":\"Is CIBER membership competitive?\",\"a\":\"Yes, incorporation is competitive; only groups that meet CIBER's quality and fit criteria are approved for membership in each annual call.\"},{\"q\":\"What are CIBER's thematic research areas?\",\"a\":\"CIBER groups work across cancer, cardiovascular disease, neurodegenerative diseases, rare diseases, infectious diseases, and respiratory health, among others. Your group should align with one or more of these areas.\"}],\"tags\":[\"spain\",\"isciii\",\"consortium-required\",\"health-research\",\"biomedical-research\",\"institutional-strengthening\",\"network\"]}",{"matchedProgram":8,"resourceSlug":8,"relatedGuides":22,"countryHubs":23,"domainHubs":24,"closingMonth":8,"hasRelated":10,"hasBrowseRelated":10},[],[],[],{"grants":26},[27,30],{"id":28,"name":29,"funder":6,"deadline":8,"budget":8},"instituto-de-salud-carlos-iii-isciii-proyectos-de-colaboraci-n-internacional-2026","Proyectos de Colaboración Internacional",{"id":31,"name":32,"funder":6,"deadline":8,"budget":8},"instituto-de-salud-carlos-iii-isciii-contratos-i-pfis-doctorados-iis-empresa-en-ciencia-2026","Contratos i-PFIS: Doctorados IIS-empresa en Ciencias y Tecnologías de la Salud"]